Plandai Biotechnology Announces Listing on Branded Ingredients Marketplace Website

LONDON, UNITED KINGDOM--(Marketwired - Jun 23, 2016) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"), producer of the highly bioavailable Phytofare® catechin complex, today announced it has registered the Company and its products on the Branded Ingredients website (www.brandedingredients.com) as a further step towards increasing product visibility with product developers. Branded Ingredients is a show case for branded ingredients manufacturers, helping them get in direct contact with potential customers. The service provides a marketplace for ingredients manufacturers and finished product developers to connect, aided by regular product updates and access to the latest news and product information.

Callum Cottrell-Duffield, vice president of sales and marketing for Plandaí, commented, "One of the biggest hurdles for new branded ingredient manufacturers to overcome is customer education. While we know the benefits of Phytofare® compared to generic green tea extracts, including the ten-times greater bioavailability and six times longer residence in the blood plasma, many product developers remain unaware of these differences. Unlike generic extracts, Phytofare® is backed by human clinical trials which show the advantages both in performance as from a cost-per-dose standpoint. As a Company, we have set as one of our goals for the coming year the need to educate manufacturers and consumers as to the clinically-proven advantages of Phytofare®. Registering on Branded Ingredients, which is a globally known and respected marketplace, allows us to rapidly disseminate news to the industry in a targeted forum that is used and relied on by our customer base."

According to the Branded-Ingredients.com website, formulating products using branded ingredients over generics allows product developers to differentiate themselves by incorporating the additional information that branded ingredients have, such as strong scientific documentation. Branded ingredients give end consumers the confidence that the product is formulated with care by choosing a superior ingredient backed with human clinical trials.

Please send all inquiries to: info@plandaibiotechnology.com

Hannah Merrill (917)900-9827

About Plandaí Biotechnology, Inc.

Plandaí Biotechnology, Inc. and its subsidiaries develop highly phyto-available™ extracts. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare® extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutriceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.

Safe Harbor Statement

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at http://www.sec.gov.